Imaging tumour-bearing animals using clinical scanners

International Journal of Radiation Biology

Volumn 85, Issue 9, 2009, Pages 752-762

  Wolf, Gunter ^a   Abolmaali, Nasreddin ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Clinical scanners; Computed tomography (CT); Experimental animal models; Experimental neoplasms; Magnetic resonance imaging (MRI); Positron emission tomography (PET)

Indexed keywords

CARBON 11; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; IODINE 124; OXYGEN 15;

ANIMAL WELFARE; ARTICLE; CANCER RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOSIMETRY; INTERMETHOD COMPARISON; IONIZING RADIATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SENSITIVITY AND SPECIFICITY;

ANIMAL WELFARE; ANIMALS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA; MUS; RATTUS;

EID: 70249109365     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000902954520     Document Type: Article

References (86)

1. Abramyuk A, Schindler S, Koch A, Tokalov S, Haberland U, Abolmaali N. 2008. Evaluierung der Tumorblutversorgung in verschiedenen Xenograft-Modellen mit dynamischer CT. RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 180:S200.
2. Alejski A, Yuteng C, Rutt BK. 2002. Ultra-high-resolution imaging with a clinical MRI. IEEE Instrumentation and Measurement Magazine 5:18-23.
3. Balaban RS, Hampshire VA. 2001. Challenges in small animal noninvasive imaging. ILAR Journal 42:248-262.
4. Barth RF. 1998. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology 36:91-102.
5. Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M. 2001. From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anatomical Record 265:85-100.
6. Bernstein MA, Zhou XJ, Polzin JA, King KF, Ganin A, Pelc NJ, Glover GH. 1998. Concomitant gradient terms in phase contrast MR: Analysis and correction. Magnetic Resonance in Medicine 39:300-308.
7. Beuf O, Jaillon F, Saint-Jalmes H. 2006. Small-animal MRI: Signal-to-noise ratio comparison at 7 and 1.5 T with multiple-animal acquisition strategies. MAGMA 19:202-208.
8. Bock NA, Konyer NB, Henkelman RM. 2003. Multiple-mouse MRI. Magnetic Resonance in Medicine 49:158-167.
9. Booth NH, McDonald LE. 1988. Veterinary pharmacology and therapeutics, 6th ed. Ames, USA: Iowa State University Press.
10. Brockmann MA, Kemmling A, Groden C. 2007. Current issues and perspectives in small rodent magnetic resonance imaging using clinical MRI scanners. Methods 43:79-87.
11. Brockmann MA, Ulmer S, Leppert J, Nadrowitz R, Wuestenberg R, Nolte I, Petersen D, Groden C, Giese A, Gottschalk S. 2006. Analysis of mouse brain using a clinical 1.5 T scanner and a standard small loop surface coil. Brain Research 1068:138-142.
12. Cai QY, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, Park SH, Juhng SK, Yoon KH. 2007. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Investigative Radiology 42:797-806.
13. Cheda A, Wrembel-Wargocka J, Lisiak E, Nowosielska EM, Marciniak M, Janiak MK. 2004. Single low doses of X rays inhibit the development of experimental tumor metastases and trigger the activities of NK cells in mice. Radiation Research 161:335-340.
14. Chen F, De Keyzer F, Wang H, Vandecaveye V, Landuyt W, Bosmans H, Hermans R, Marchal G, Ni Y. 2007. Diffusion weighted imaging in small rodents using clinical MRI scanners. Methods 43:12-20.
15. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG. 1997. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data. Magnetic Resonance in Medicine 38:389-398.
16. Cherry SR. 2006. The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons) - advances in PET imaging technology. Journal of Nuclear Medicine 47:1735-1745.
17. Colby LA, Morenko BJ. 2004. Clinical considerations in rodent bioimaging. Comparative Medicine 54:623-630.
18. Day TK, Zeng G, Hooker AM, Bhat M, Scott BR, Turner DR, Sykes PJ. 2006. Extremely low priming doses of X radiation induce an adaptive response for chromosomal inversions in pKZ1 mouse prostate. Radiation Research 166:757-766.
19. de Bazelaire C, Siauve N, Fournier L, Frouin F, Robert P, Clement O, de Kerviler E, Cuenod CA. 2005. Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats' rhabdomyosarcoma. European Radiology 15:2497-2505.
20. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal JM, van de Vorstenbosch C. 2001. A good practice guide to the administration of substances and removal of blood, including routes and volumes. Journal of Applied Toxicology 21:15-23.
21. European Commission. 2007. Commission Staff Working Document - Annex to the 5th Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union. Report nr. SEC/2007/1455, COM/2007/675 final, released: 05.11. 2007, Brussels. Available from the website: http://ec.europa. eu/environment/chemicals/lab- animals/reports-en.htm.
22. Fan G, Zang P, Jing F, Wu Z, Guo Q. 2005. Usefulness of diffusion/perfusion-weighted MRI in rat gliomas: Correlation with histopathology. Academic Radiology 12:640-651.
23. Fink C, Kiessling F, Bock M, Lichy MP, Misselwitz B, Peschke P, Fusenig NE, Grobholz R, Delorme S. 2003. High-resolution three-dimensional MR angiography of rodent tumors: Morphologic characterization of intratumoral vasculature. Journal of Magnetic Resonance Imaging 18:59-65.
24. Flecknell PA. 1993. Anaesthesia of animals for biomedical research. British Journal of Anaesthesia 71:885-894.
25. Ford NL, Thornton MM, Holdsworth DW. 2003. Fundamental image quality limits for microcomputed tomography in small animals. Medical Physics 30:2869-2877.
26. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA. 2006. Impact of animal handling on the results of 18F-FDG PET studies in mice. Journal of Nuclear Medicine 47:999-1006.
27. Fujimori A, Okayasu R, Ishihara H, Yoshida S, Eguchi-Kasai K, Nojima K, Ebisawa S, Takahashi S. 2005. Extremely low dose ionizing radiation up-regulates CXC chemokines in normal human fibroblasts. Cancer Research 65:10159-10163.
28. Gale ME, Robbins AH, Hamburger RJ, Widrich WC. 1984. Renal toxicity of contrast agents: Iopamidol, iothalamate, and diatrizoate. AJR. American Journal of Roentgenology 142:333-335.
29. Ginefri JC, Poirier-Quinot M, Girard O, Darrasse L. 2007. Technical aspects: Development, manufacture and installation of a cryo-cooled HTS coil system for high-resolution in-vivo imaging of the mouse at 1.5 T. Methods 43:54-67.
30. Ginefri JC, Poirier-Quinot M, Robert P, Darrasse L. 2005. Contrast-enhanced dynamic MRI protocol with improved spatial and time resolution for in vivo microimaging of the mouse with a 1.5-T body scanner and a superconducting surface coil. Magnetic Resonance Imaging 23:239-243.
31. Griffin JL, Shockcor JP. 2004. Metabolic profiles of cancer cells. Nature Reviews Cancer 4:551-561.
32. Grippo PJ, Sandgren EP. 2005. Modeling pancreatic cancer in animals to address specific hypotheses. Methods in Molecular Medicine 103:217-243.
33. Gueant-Rodriguez RM, Romano A, Barbaud A, Brockow K, Gueant JL. 2006. Hypersensitivity reactions to iodinated contrast media. Current Pharmaceutical Design 12:3359-3372.
34. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. 2006. Gold nanoparticles: A new X-ray contrast agent. British Journal of Radiology 79:248-253.
35. Hall EJ, Giaccia AJ. 2006. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott Williams and Wilkins.
36. Hanusch C, Hoeger S, Beck GC. 2007. Anaesthesia of small rodents during magnetic resonance imaging. Methods 43:68-78.
37. Heijstek MW, Kranenburg O, Borel Rinkes IH. 2005. Mouse models of colorectal cancer and liver metastases. Digestive Surgery 22:16-25.
38. Heindl C, Hess A, Brune K. 2008. Refinement and reduction in animal experimentation: Options for new imaging techniques. ALTEX 25:121-125.
39. Herneth AM, Guccione S, Bednarski M. 2003. Apparent diffusion coefficient: A quantitative parameter for in vivo tumor characterization. European Journal of Radiology 45:208-213.
40. Hildebrandt IJ, Su H, Weber WA. 2008. Anesthesia and other considerations for in vivo imaging of small animals. ILAR Journal 49:17-26.
41. Imam SK. 2005. Molecular nuclear imaging: The radiopharmaceuticals (review). Cancer Biotherapy and Radiopharmaceuticals 20:163-172.
42. Inderbitzin D, Stoupis C, Sidler D, Gass M, Candinas D. 2007. Abdominal magnetic resonance imaging in small rodents using a clinical 1.5 T MR scanner. Methods 43:46-53.
43. Kiessling F, Heilmann M, Vosseler S, Lichy M, Krix M, Fink C, Kiessling I, Steinbauer H, Schad L, Fusenig NE, Delorme S. 2003. Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging. International Journal of Cancer 104:113-120.
44. Kim CF, Jackson EL, Kirsch DG, Grimm J, Shaw AT, Lane K, Kissil J, Olive KP, Sweet-Cordero A, Weissleder R, Jacks T. 2005. Mouse models of human non-small-cell lung cancer: Raising the bar. Cold Spring Harbor Symposia on Quantitative Biology 70:241-250.
45. Kunsch K, Kunsch S. 2000. Der Mensch in Zahlen, 2nd ed. Spektrum. Heidelberg, Berlin: Akademischer Verlag.
46. Kwok WE, You Z. 2006. In vivo MRI using liquid nitrogen cooled phased array coil at 3.0 T. Magnetic Resonance Imaging 24:819-823.
47. LaManna JC, Harik SI. 1986. Regional studies of blood-brain barrier transport of glucose and leucine in awake and anesthetized rats. Journal of Cerebral Blood Flow and Metabolism 6:717-723.
48. Landuyt W, Hermans R, Bosmans H, Sunaert S, Beatse E, Farina D, Meijerink M, Zhang H, Van Den Bogaert W, Lambin P, Marchal G. 2001. BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T. European Radiology 11:2332-2340.
49. Lee KH, Ko BH, Paik JY, Jung KH, Choe YS, Choi Y, Kim BT. 2005. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice. Journal of Nuclear Medicine 46:1531-1536.
50. Linn J, Schwarz F, Schichor C, Wiesmann M. 2007. Cranial MRI of small rodents using a clinical MR scanner. Methods 43:2-11.
51. Lukasik VM, Gillies RJ. 2003. Animal anaesthesia for in vivo magnetic resonance. NMR in Biomedicine 16:459-467.
52. Lyons SK. 2005. Advances in imaging mouse tumour models in vivo. Journal of Pathology 205:194-205.
53. Mankoff DA, Bellon JR. 2001. Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond. Seminars in Radiation Oncology 11:16-27.
54. Mercer JR. 2007. Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglu-cose (FDG): Applications, limitations and potential. Journal of Pharmacy and Pharmaceutical Sciences 10:180-202.
55. Montet-Abou K, Daire JL, Ivancevic MK, Hyacinthe JN, Nguyen D, Jorge-Costa M, Morel DR, Vallee JP. 2006. Optimization of cardiac cine in the rat on a clinical 1.5-T MR system. MAGMA 19:144-151.
56. Morton DB, Jennings M, Buckwell A, Ewbank R, Godfrey C, Holgate B, Inglis I, James R, Page C, Sharman I, Verschoyle R, Westall L, Wilson AB. 2001. Refining procedures for the administration of substances. Report of the BVAAWF/ FRAME/RSPCA/UFAW Joint Working Group on Refine-ment. British Veterinary Association Animal Welfare Foundation/Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Prevention of Cruelty to Animals/Universities Federation for Animal Welfare. Laboratory Animals 35:1-41.
57. Muruganandham M, Lupu M, Dyke JP, Matei C, Linn M, Packman K, Kolinsky K, Higgins B, Koutcher JA. 2006. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Molecular Cancer Therapeutics 5:1950-1957.
58. Oliveira PA, Colaco A, De la Cruz PL, Lopes C. 2006. Experimental bladder carcinogenesis-rodent models. Experimental Oncology 28:2-11.
59. Pandey R, Shankar BS, Sharma D, Sainis KB. 2005. Low dose radiation induced immunomodulation: Effect on macrophages and CD8+T cells. International Journal of Radiation Biology 81:801-812.
60. Phelps ME. 2000. Positron emission tomography provides molecular imaging of biological processes. Proceedings of the National Academy of Sciences of the United States of America 97: 9226-9233.
61. Pichler BJ, Wehrl HF, Kolb A, Judenhofer MS. 2008. Positron emission tomography/magnetic resonance imaging: The next generation of multimodality imaging? Seminars in Nuclear Medicine 38:199-208.
62. Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, Carey TE, Kopelman R. 2008. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Letters 8: 4593-4596.
63. Qiu HH, Cofer GP, Hedlund LW, Johnson GA. 1997. Automated feedback control of body temperature for small animal studies with MR microscopy. IEEE Transactions on Biomedical Engineering 44:1107-1113.
64. Robinson MK, Doss M, Shaller C, Narayanan D, Marks JD, Adler LP, Gonzalez Trotter DE, Adams GP. 2005. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Research 65:1471-1478.
65. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH. 2003. Animal models of bone metastasis. Cancer 97:748-757.
66. Rowland DJ, Cherry SR. 2008. Small-animal preclinical nuclear medicine instrumentation and methodology. Seminars in Nuclear Medicine 38:209-222.
67. Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM. 2005. Molecular MR imaging of melanoma angiogenesis with anb3-targeted paramagnetic nanoparticles. Magnetic Resonance in Medicine 53:621-627.
68. Seemann MD. 2004. Human PET/CT scanners: Feasibility for oncological in vivo imaging in mice. European Journal of Medical Research 9:468-472.
69. Seemann MD, Beck R, Ziegler S. 2006. In vivo tumor imaging in mice using a state-of-the-art clinical PET/CT in comparison with a small animal PET and a small animal CT. Technology in Cancer Research and Treatment 5:537-542.
70. Szczesny G, Veihelmann A, Massberg S, Nolte D, Messmer K. 2004. Long-term anaesthesia using inhalatory isoflurane in different strains of mice-the haemodynamic effects. Laboratory Animals 38:64-69.
71. Taschereau R, Chatziioannou AF. 2007. Monte Carlo simulations of absorbed dose in a mouse phantom from 18-fluorine compounds. Medical Physics 34:1026-1036.
72. Taschereau R, Chow PL, Chatziioannou AF. 2006. Monte Carlo simulations of dose from microCT imaging procedures in a realistic mouse phantom. Medical Physics 33:216-224.
73. Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL. 2003. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D- glucose. Cancer Research 63:6252-6257.
74. Thoeny HC, De Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, Hermans R, Verbeken EK, Boesch C, Marchal G, Landuyt W, Ni Y. 2005. Effect of vascular targeting agent in rat tumor model: Dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237:492-499.
75. Thorsen F, Ersland L, Nordli H, Enger PO, Huszthy PC, Lundervold A, Standnes T, Bjerkvig R, Lund-Johansen M. 2003. Imaging of experimental rat gliomas using a clinical MR scanner. Journal of Neuro-Oncology 63:225-231.
76. Topal A, Gul N, Ilcol Y, Gorgul OS. 2003. Hepatic effects of halothane, isoflurane or sevoflurane anaesthesia in dogs. Journal of Veterinary Medicine, Series A: Physiology, Pathology, Clinical Medicine 50:530-533.
77. Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, Seidel J, Green MV, Innis RB. 2004. Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET. Nuclear Medicine and Biology 31:251-256.
78. Ulmer S, Reeh M, Krause J, Herdegen T, Heldt-Feindt J, Jansen O, Rohr A. 2008. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47mm at a clinical 1.5T scanner. Journal of Neuroscience Methods 172:168-172.
79. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR). 1998. UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia. 2nd ed. British Journal of Cancer 77:1-10.
80. van Furth WR, Laughlin S, Taylor MD, Salhia B, Mainprize T, Henkelman M, Cusimano MD, Ackerley C, Rutka JT. 2003. Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system. Canadian Journal of Neurological Sciences 30:326-332.
81. van Zutphen LFM, Baumans V, Beynen AC. 2001. Principles of laboratory animal science. Rev ed. Amsterdam: Elsevier.
82. Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM. 2003. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel anb3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Research 63:5838-5843.
83. Wolf G, Grüner S, Schindler S, Koch A, Tokalov S, Laniado M, Baumann M, Abolmaali N. 2007. Diffusionsgewichtete und morphologische Ganzkörper-MRT der Ratte bei 1.5 T. RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 179:S272.
84. Xu S, Gade TP, Matei C, Zakian K, Alfieri AA, Hu X, Holland EC, Soghomonian S, Tjuvajev J, Ballon D, Koutcher JA. 2003. In vivo multiple-mouse imaging at 1.5 T. Magnetic Resonance in Medicine 49:551-557.
85. Yu HS, Song AQ, Lu YD, Qiu WS, Shen FZ. 2004. Effects of low-dose radiation on tumor growth, erythrocyte immune function and SOD activity in tumor-bearing mice. Chinese Medical Journal 117:1036-1039.
86. Zhang C, Jugold M, Woenne EC, Lammers T, Morgenstern B, Mueller MM, Zentgraf H, Bock M, Eisenhut M, Semmler W, Kiessling F. 2007. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Research 67:1555-1562.